0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Seafood Allergy Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-37M17216
Home | Market Reports | Food & Drink| Food| Meat & Seafood
Global Seafood Allergy Treatment Market Research Report 2024
BUY CHAPTERS

Global Seafood Allergy Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-37M17216
Report
November 2025
Pages:171
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Seafood Allergy Treatment Market

The global Seafood Allergy Treatment market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, < 18 Years Old accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Seafood Allergy Treatment leading manufacturers including Creative Biolabs, Peanut Allergy Therapeutics, Genentech, Roche, Novartis, Aimmune, Bayer, Perrigo, Mylan, J & J, etc., dominate supply; the top five capture approximately % of global revenue, with Creative Biolabs leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Seafood Allergy Treatment market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Seafood Allergy Treatment Market Report

Report Metric Details
Report Name Seafood Allergy Treatment Market
Segment by Type
  • Epinephrine Injection
  • Antihistamines
  • Omalizumab
  • Others
Segment by Application
  • < 18 Years Old
  • 18-35 Years Old
  • 35-50 Years Old
  • >50 Years Old
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Creative Biolabs, Peanut Allergy Therapeutics, Genentech, Roche, Novartis, Aimmune, Bayer, Perrigo, Mylan, J & J, GSK, ALK Abello, UCB Pharma, Aimmune Therapeutics, Kaleo, HUAPONT Pharm, Amneal Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Seafood Allergy Treatment study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Seafood Allergy Treatment Market report?

Ans: The main players in the Seafood Allergy Treatment Market are Creative Biolabs, Peanut Allergy Therapeutics, Genentech, Roche, Novartis, Aimmune, Bayer, Perrigo, Mylan, J & J, GSK, ALK Abello, UCB Pharma, Aimmune Therapeutics, Kaleo, HUAPONT Pharm, Amneal Pharma

What are the Application segmentation covered in the Seafood Allergy Treatment Market report?

Ans: The Applications covered in the Seafood Allergy Treatment Market report are < 18 Years Old, 18-35 Years Old, 35-50 Years Old, >50 Years Old

What are the Type segmentation covered in the Seafood Allergy Treatment Market report?

Ans: The Types covered in the Seafood Allergy Treatment Market report are Epinephrine Injection, Antihistamines, Omalizumab, Others

1 Study Coverage
1.1 Introduction to Seafood Allergy Treatment: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Seafood Allergy Treatment Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Epinephrine Injection
1.2.3 Antihistamines
1.2.4 Omalizumab
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Seafood Allergy Treatment Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 < 18 Years Old
1.3.3 18-35 Years Old
1.3.4 35-50 Years Old
1.3.5 >50 Years Old
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Seafood Allergy Treatment Revenue Estimates and Forecasts 2020-2031
2.2 Global Seafood Allergy Treatment Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Seafood Allergy Treatment Sales Estimates and Forecasts 2020-2031
2.4 Global Seafood Allergy Treatment Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Seafood Allergy Treatment Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Seafood Allergy Treatment Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Epinephrine Injection Market Size by Manufacturers
3.5.2 Antihistamines Market Size by Manufacturers
3.5.3 Omalizumab Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Seafood Allergy Treatment Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Seafood Allergy Treatment Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Seafood Allergy Treatment Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Seafood Allergy Treatment Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Seafood Allergy Treatment Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Seafood Allergy Treatment Sales and Revenue by Type (2020-2031)
6.4 North America Seafood Allergy Treatment Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Seafood Allergy Treatment Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Seafood Allergy Treatment Sales and Revenue by Type (2020-2031)
7.4 Europe Seafood Allergy Treatment Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Seafood Allergy Treatment Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Seafood Allergy Treatment Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Seafood Allergy Treatment Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Seafood Allergy Treatment Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Seafood Allergy Treatment Sales and Revenue by Type (2020-2031)
9.4 Central and South America Seafood Allergy Treatment Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Seafood Allergy Treatment Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Seafood Allergy Treatment Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Seafood Allergy Treatment Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Seafood Allergy Treatment Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Creative Biolabs
11.1.1 Creative Biolabs Corporation Information
11.1.2 Creative Biolabs Business Overview
11.1.3 Creative Biolabs Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.1.4 Creative Biolabs Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Creative Biolabs Seafood Allergy Treatment Sales by Product in 2024
11.1.6 Creative Biolabs Seafood Allergy Treatment Sales by Application in 2024
11.1.7 Creative Biolabs Seafood Allergy Treatment Sales by Geographic Area in 2024
11.1.8 Creative Biolabs Seafood Allergy Treatment SWOT Analysis
11.1.9 Creative Biolabs Recent Developments
11.2 Peanut Allergy Therapeutics
11.2.1 Peanut Allergy Therapeutics Corporation Information
11.2.2 Peanut Allergy Therapeutics Business Overview
11.2.3 Peanut Allergy Therapeutics Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.2.4 Peanut Allergy Therapeutics Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Peanut Allergy Therapeutics Seafood Allergy Treatment Sales by Product in 2024
11.2.6 Peanut Allergy Therapeutics Seafood Allergy Treatment Sales by Application in 2024
11.2.7 Peanut Allergy Therapeutics Seafood Allergy Treatment Sales by Geographic Area in 2024
11.2.8 Peanut Allergy Therapeutics Seafood Allergy Treatment SWOT Analysis
11.2.9 Peanut Allergy Therapeutics Recent Developments
11.3 Genentech
11.3.1 Genentech Corporation Information
11.3.2 Genentech Business Overview
11.3.3 Genentech Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.3.4 Genentech Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Genentech Seafood Allergy Treatment Sales by Product in 2024
11.3.6 Genentech Seafood Allergy Treatment Sales by Application in 2024
11.3.7 Genentech Seafood Allergy Treatment Sales by Geographic Area in 2024
11.3.8 Genentech Seafood Allergy Treatment SWOT Analysis
11.3.9 Genentech Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Business Overview
11.4.3 Roche Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.4.4 Roche Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Roche Seafood Allergy Treatment Sales by Product in 2024
11.4.6 Roche Seafood Allergy Treatment Sales by Application in 2024
11.4.7 Roche Seafood Allergy Treatment Sales by Geographic Area in 2024
11.4.8 Roche Seafood Allergy Treatment SWOT Analysis
11.4.9 Roche Recent Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Business Overview
11.5.3 Novartis Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.5.4 Novartis Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Novartis Seafood Allergy Treatment Sales by Product in 2024
11.5.6 Novartis Seafood Allergy Treatment Sales by Application in 2024
11.5.7 Novartis Seafood Allergy Treatment Sales by Geographic Area in 2024
11.5.8 Novartis Seafood Allergy Treatment SWOT Analysis
11.5.9 Novartis Recent Developments
11.6 Aimmune
11.6.1 Aimmune Corporation Information
11.6.2 Aimmune Business Overview
11.6.3 Aimmune Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.6.4 Aimmune Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Aimmune Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Business Overview
11.7.3 Bayer Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.7.4 Bayer Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Bayer Recent Developments
11.8 Perrigo
11.8.1 Perrigo Corporation Information
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.8.4 Perrigo Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Perrigo Recent Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Business Overview
11.9.3 Mylan Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.9.4 Mylan Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Mylan Recent Developments
11.10 J & J
11.10.1 J & J Corporation Information
11.10.2 J & J Business Overview
11.10.3 J & J Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.10.4 J & J Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 J & J Recent Developments
11.11 GSK
11.11.1 GSK Corporation Information
11.11.2 GSK Business Overview
11.11.3 GSK Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.11.4 GSK Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 GSK Recent Developments
11.12 ALK Abello
11.12.1 ALK Abello Corporation Information
11.12.2 ALK Abello Business Overview
11.12.3 ALK Abello Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.12.4 ALK Abello Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 ALK Abello Recent Developments
11.13 UCB Pharma
11.13.1 UCB Pharma Corporation Information
11.13.2 UCB Pharma Business Overview
11.13.3 UCB Pharma Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.13.4 UCB Pharma Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 UCB Pharma Recent Developments
11.14 Aimmune Therapeutics
11.14.1 Aimmune Therapeutics Corporation Information
11.14.2 Aimmune Therapeutics Business Overview
11.14.3 Aimmune Therapeutics Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.14.4 Aimmune Therapeutics Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Aimmune Therapeutics Recent Developments
11.15 Kaleo
11.15.1 Kaleo Corporation Information
11.15.2 Kaleo Business Overview
11.15.3 Kaleo Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.15.4 Kaleo Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Kaleo Recent Developments
11.16 HUAPONT Pharm
11.16.1 HUAPONT Pharm Corporation Information
11.16.2 HUAPONT Pharm Business Overview
11.16.3 HUAPONT Pharm Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.16.4 HUAPONT Pharm Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 HUAPONT Pharm Recent Developments
11.17 Amneal Pharma
11.17.1 Amneal Pharma Corporation Information
11.17.2 Amneal Pharma Business Overview
11.17.3 Amneal Pharma Seafood Allergy Treatment Product Models, Descriptions and Specifications
11.17.4 Amneal Pharma Seafood Allergy Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Amneal Pharma Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Seafood Allergy Treatment Industry Chain
12.2 Seafood Allergy Treatment Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Seafood Allergy Treatment Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Seafood Allergy Treatment Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Seafood Allergy Treatment Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Seafood Allergy Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Seafood Allergy Treatment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Seafood Allergy Treatment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Seafood Allergy Treatment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Seafood Allergy Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Seafood Allergy Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Seafood Allergy Treatment Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Seafood Allergy Treatment Sales by Region (2020-2025) & (K Units)
 Table 8. Global Seafood Allergy Treatment Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Seafood Allergy Treatment Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Seafood Allergy Treatment Sales Share by Manufacturers (2020-2025)
 Table 12. Global Seafood Allergy Treatment Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Seafood Allergy Treatment Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Seafood Allergy Treatment by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seafood Allergy Treatment as of 2024)
 Table 16. Global Seafood Allergy Treatment Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Seafood Allergy Treatment Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Seafood Allergy Treatment Manufacturing Base and Headquarters
 Table 19. Global Seafood Allergy Treatment Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Seafood Allergy Treatment Sales by Type (2020-2025) & (K Units)
 Table 23. Global Seafood Allergy Treatment Sales by Type (2026-2031) & (K Units)
 Table 24. Global Seafood Allergy Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Seafood Allergy Treatment Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Seafood Allergy Treatment ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Seafood Allergy Treatment Sales by Application (2020-2025) & (K Units)
 Table 29. Global Seafood Allergy Treatment Sales by Application (2026-2031) & (K Units)
 Table 30. Seafood Allergy Treatment High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Seafood Allergy Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Seafood Allergy Treatment Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Seafood Allergy Treatment ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Seafood Allergy Treatment Growth Accelerators and Market Barriers
 Table 37. North America Seafood Allergy Treatment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Seafood Allergy Treatment Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Seafood Allergy Treatment Growth Accelerators and Market Barriers
 Table 40. Europe Seafood Allergy Treatment Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Seafood Allergy Treatment Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Seafood Allergy Treatment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Seafood Allergy Treatment Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Seafood Allergy Treatment Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Seafood Allergy Treatment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Seafood Allergy Treatment Investment Opportunities and Key Challenges
 Table 47. Central and South America Seafood Allergy Treatment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Seafood Allergy Treatment Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Seafood Allergy Treatment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Creative Biolabs Corporation Information
 Table 51. Creative Biolabs Description and Major Businesses
 Table 52. Creative Biolabs Product Models, Descriptions and Specifications
 Table 53. Creative Biolabs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Creative Biolabs Sales Value Proportion by Product in 2024
 Table 55. Creative Biolabs Sales Value Proportion by Application in 2024
 Table 56. Creative Biolabs Sales Value Proportion by Geographic Area in 2024
 Table 57. Creative Biolabs Seafood Allergy Treatment SWOT Analysis
 Table 58. Creative Biolabs Recent Developments
 Table 59. Peanut Allergy Therapeutics Corporation Information
 Table 60. Peanut Allergy Therapeutics Description and Major Businesses
 Table 61. Peanut Allergy Therapeutics Product Models, Descriptions and Specifications
 Table 62. Peanut Allergy Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Peanut Allergy Therapeutics Sales Value Proportion by Product in 2024
 Table 64. Peanut Allergy Therapeutics Sales Value Proportion by Application in 2024
 Table 65. Peanut Allergy Therapeutics Sales Value Proportion by Geographic Area in 2024
 Table 66. Peanut Allergy Therapeutics Seafood Allergy Treatment SWOT Analysis
 Table 67. Peanut Allergy Therapeutics Recent Developments
 Table 68. Genentech Corporation Information
 Table 69. Genentech Description and Major Businesses
 Table 70. Genentech Product Models, Descriptions and Specifications
 Table 71. Genentech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Genentech Sales Value Proportion by Product in 2024
 Table 73. Genentech Sales Value Proportion by Application in 2024
 Table 74. Genentech Sales Value Proportion by Geographic Area in 2024
 Table 75. Genentech Seafood Allergy Treatment SWOT Analysis
 Table 76. Genentech Recent Developments
 Table 77. Roche Corporation Information
 Table 78. Roche Description and Major Businesses
 Table 79. Roche Product Models, Descriptions and Specifications
 Table 80. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Roche Sales Value Proportion by Product in 2024
 Table 82. Roche Sales Value Proportion by Application in 2024
 Table 83. Roche Sales Value Proportion by Geographic Area in 2024
 Table 84. Roche Seafood Allergy Treatment SWOT Analysis
 Table 85. Roche Recent Developments
 Table 86. Novartis Corporation Information
 Table 87. Novartis Description and Major Businesses
 Table 88. Novartis Product Models, Descriptions and Specifications
 Table 89. Novartis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Novartis Sales Value Proportion by Product in 2024
 Table 91. Novartis Sales Value Proportion by Application in 2024
 Table 92. Novartis Sales Value Proportion by Geographic Area in 2024
 Table 93. Novartis Seafood Allergy Treatment SWOT Analysis
 Table 94. Novartis Recent Developments
 Table 95. Aimmune Corporation Information
 Table 96. Aimmune Description and Major Businesses
 Table 97. Aimmune Product Models, Descriptions and Specifications
 Table 98. Aimmune Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Aimmune Recent Developments
 Table 100. Bayer Corporation Information
 Table 101. Bayer Description and Major Businesses
 Table 102. Bayer Product Models, Descriptions and Specifications
 Table 103. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Bayer Recent Developments
 Table 105. Perrigo Corporation Information
 Table 106. Perrigo Description and Major Businesses
 Table 107. Perrigo Product Models, Descriptions and Specifications
 Table 108. Perrigo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Perrigo Recent Developments
 Table 110. Mylan Corporation Information
 Table 111. Mylan Description and Major Businesses
 Table 112. Mylan Product Models, Descriptions and Specifications
 Table 113. Mylan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Mylan Recent Developments
 Table 115. J & J Corporation Information
 Table 116. J & J Description and Major Businesses
 Table 117. J & J Product Models, Descriptions and Specifications
 Table 118. J & J Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. J & J Recent Developments
 Table 120. GSK Corporation Information
 Table 121. GSK Description and Major Businesses
 Table 122. GSK Product Models, Descriptions and Specifications
 Table 123. GSK Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. GSK Recent Developments
 Table 125. ALK Abello Corporation Information
 Table 126. ALK Abello Description and Major Businesses
 Table 127. ALK Abello Product Models, Descriptions and Specifications
 Table 128. ALK Abello Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. ALK Abello Recent Developments
 Table 130. UCB Pharma Corporation Information
 Table 131. UCB Pharma Description and Major Businesses
 Table 132. UCB Pharma Product Models, Descriptions and Specifications
 Table 133. UCB Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. UCB Pharma Recent Developments
 Table 135. Aimmune Therapeutics Corporation Information
 Table 136. Aimmune Therapeutics Description and Major Businesses
 Table 137. Aimmune Therapeutics Product Models, Descriptions and Specifications
 Table 138. Aimmune Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Aimmune Therapeutics Recent Developments
 Table 140. Kaleo Corporation Information
 Table 141. Kaleo Description and Major Businesses
 Table 142. Kaleo Product Models, Descriptions and Specifications
 Table 143. Kaleo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Kaleo Recent Developments
 Table 145. HUAPONT Pharm Corporation Information
 Table 146. HUAPONT Pharm Description and Major Businesses
 Table 147. HUAPONT Pharm Product Models, Descriptions and Specifications
 Table 148. HUAPONT Pharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. HUAPONT Pharm Recent Developments
 Table 150. Amneal Pharma Corporation Information
 Table 151. Amneal Pharma Description and Major Businesses
 Table 152. Amneal Pharma Product Models, Descriptions and Specifications
 Table 153. Amneal Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 154. Amneal Pharma Recent Developments
 Table 155. Key Raw Materials Distribution
 Table 156. Raw Materials Key Suppliers
 Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 158. Milestones in Production Technology Evolution
 Table 159. Distributors List
 Table 160. Market Trends and Market Evolution
 Table 161. Market Drivers and Opportunities
 Table 162. Market Challenges, Risks, and Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources


List of Figures
 Figure 1. Seafood Allergy Treatment Product Picture
 Figure 2. Global Seafood Allergy Treatment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Epinephrine Injection Product Picture
 Figure 4. Antihistamines Product Picture
 Figure 5. Omalizumab Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Seafood Allergy Treatment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. < 18 Years Old
 Figure 9. 18-35 Years Old
 Figure 10. 35-50 Years Old
 Figure 11. >50 Years Old
 Figure 12. Seafood Allergy Treatment Report Years Considered
 Figure 13. Global Seafood Allergy Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Seafood Allergy Treatment Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Seafood Allergy Treatment Revenue Market Share by Region (2020-2031)
 Figure 17. Global Seafood Allergy Treatment Sales (2020-2031) & (K Units)
 Figure 18. Global Seafood Allergy Treatment Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 19. Global Seafood Allergy Treatment Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Seafood Allergy Treatment Sales Volume Market Share in 2024
 Figure 21. Global Seafood Allergy Treatment Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Epinephrine Injection Revenue Market Share by Manufacturer in 2024
 Figure 24. Antihistamines Revenue Market Share by Manufacturer in 2024
 Figure 25. Omalizumab Revenue Market Share by Manufacturer in 2024
 Figure 26. Others Revenue Market Share by Manufacturer in 2024
 Figure 27. Global Seafood Allergy Treatment Sales Market Share by Type (2020-2031)
 Figure 28. Global Seafood Allergy Treatment Revenue Market Share by Type (2020-2031)
 Figure 29. Global Seafood Allergy Treatment Sales Market Share by Application (2020-2031)
 Figure 30. Global Seafood Allergy Treatment Revenue Market Share by Application (2020-2031)
 Figure 31. North America Seafood Allergy Treatment Sales YoY (2020-2031) & (K Units)
 Figure 32. North America Seafood Allergy Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. North America Top 5 Manufacturers Seafood Allergy Treatment Sales Revenue (US$ Million) in 2024
 Figure 34. North America Seafood Allergy Treatment Sales Volume (K Units) by Type (2020- 2031)
 Figure 35. North America Seafood Allergy Treatment Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America Seafood Allergy Treatment Sales Volume (K Units) by Application (2020-2031)
 Figure 37. North America Seafood Allergy Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 38. US Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 39. Canada Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 40. Mexico Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 41. Europe Seafood Allergy Treatment Sales YoY (2020-2031) & (K Units)
 Figure 42. Europe Seafood Allergy Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Europe Top 5 Manufacturers Seafood Allergy Treatment Sales Revenue (US$ Million) in 2024
 Figure 44. Europe Seafood Allergy Treatment Sales Volume (K Units) by Type (2020-2031)
 Figure 45. Europe Seafood Allergy Treatment Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Europe Seafood Allergy Treatment Sales Volume (K Units) by Application (2020-2031)
 Figure 47. Europe Seafood Allergy Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Germany Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 49. France Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 50. U.K. Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 51. Italy Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 52. Russia Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Seafood Allergy Treatment Sales YoY (2020-2031) & (K Units)
 Figure 54. Asia-Pacific Seafood Allergy Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Asia-Pacific Top 8 Manufacturers Seafood Allergy Treatment Sales Revenue (US$ Million) in 2024
 Figure 56. Asia-Pacific Seafood Allergy Treatment Sales Volume (K Units) by Type (2020- 2031)
 Figure 57. Asia-Pacific Seafood Allergy Treatment Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 58. Asia-Pacific Seafood Allergy Treatment Sales Volume (K Units) by Application (2020-2031)
 Figure 59. Asia-Pacific Seafood Allergy Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Indonesia Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 61. Japan Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 62. South Korea Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 63. China Taiwan Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 64. India Seafood Allergy Treatment Revenue (2020-2031) & (US$ Million)
 Figure 65. Central and South America Seafood Allergy Treatment Sales YoY (2020-2031) & (K Units)
 Figure 66. Central and South America Seafood Allergy Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 67. Central and South America Top 5 Manufacturers Seafood Allergy Treatment Sales Revenue (US$ Million) in 2024
 Figure 68. Central and South America Seafood Allergy Treatment Sales Volume (K Units) by Type (2021-2031)
 Figure 69. Central and South America Seafood Allergy Treatment Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 70. Central and South America Seafood Allergy Treatment Sales Volume (K Units) by Application (2020-2031)
 Figure 71. Central and South America Seafood Allergy Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 72. Brazil Seafood Allergy Treatment Revenue (2020-2025) & (US$ Million)
 Figure 73. Argentina Seafood Allergy Treatment Revenue (2020-2025) & (US$ Million)
 Figure 74. Middle East, and Africa Seafood Allergy Treatment Sales YoY (2020-2031) & (K Units)
 Figure 75. Middle East and Africa Seafood Allergy Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Middle East and Africa Top 5 Manufacturers Seafood Allergy Treatment Sales Revenue (US$ Million) in 2024
 Figure 77. Middle East and Africa Seafood Allergy Treatment Sales Volume (K Units) by Type (2021-2031)
 Figure 78. South America Seafood Allergy Treatment Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Middle East and Africa Seafood Allergy Treatment Sales Volume (K Units) by Application (2020-2031)
 Figure 80. Middle East and Africa Seafood Allergy Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. GCC Countries Seafood Allergy Treatment Revenue (2020-2025) & (US$ Million)
 Figure 82. Turkey Seafood Allergy Treatment Revenue (2020-2025) & (US$ Million)
 Figure 83. Egypt Seafood Allergy Treatment Revenue (2020-2025) & (US$ Million)
 Figure 84. South Africa Seafood Allergy Treatment Revenue (2020-2025) & (US$ Million)
 Figure 85. Seafood Allergy Treatment Industry Chain Mapping
 Figure 86. Regional Seafood Allergy Treatment Manufacturing Base Distribution (%)
 Figure 87. Global Seafood Allergy Treatment Production Market Share by Region (2020-2031)
 Figure 88. Seafood Allergy Treatment Production Process
 Figure 89. Regional Seafood Allergy Treatment Production Cost Structure
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Seafood X-Ray Inspection Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24V19789
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Seafood Supply Chain Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25A19894
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Grass-fed Chicken Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29Y19826
Wed Nov 19 00:00:00 UTC 2025

Add to Cart

Global Commercial Salmon Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18O17159
Wed Nov 12 00:00:00 UTC 2025

Add to Cart